No Data
Express News | Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target
HeartSciences Analyst Ratings
HeartSciences Withdraws June 2023 Filing for Potential Stock Sale
Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate
HeartSciences: Saw Across-the-Bd Progress, Positive Developments for Field of AI-ECG, MyoVista WavECG Device, MyoVista Insights Cloud-Native Platform and First Cloud-Based AI-ECG Algorithms >HSCS
HeartSciences: No Rev During 2Q FY25. as of Oct 31, 2024, Cash and Cash Equivalents Were Approximately $4.1M and Shareholders' Equity Was Approximately $4.0M >HSCS
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
152258659 : Hello from Australia Mate, Thanks for your valuable input. Cheers
HannChau :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
i was not able to invest US stock anymore until January 2024 as i break my country FEP limit ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
I can only watch now ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Jaguar8 OP HannChau : Oh
Bellaah : Are you on twitter or Stocktwits
Jaguar8 OP Bellaah : None. Why?
View more comments...